Thorough analysis reveals immune system dynamics after immunotherapyEurekAlert (press release)Immunotherapy is a rapidly growing field in which the immune system of patients is manipulated in order to fight disease, and in which considerable progress i… Continue reading
|
Brainstorm Health: Hospitals and Harvey, VR Dementia Research, Stem Cell ‘Bad Actors’
Fortune Hurricane Harvey has absolutely devastated Texas cities like Houston with powerful winds and torrential downpours. At least ten deaths have been reported so far (the full figure may become much higher once the flood recedes and authorities can check up … |
|
How your own stem cells could relieve your chronic pain
Good4Utah Dr. Khan from Wasatch Pain Solutions gave us insight to Regenexx, the world’s most advanced stem cell and blood platelet procedures. On what makes Regenexx treatments better than any other, Dr. Khan explained that a network of doctors and researchers … |
Medical Design & Outsourcing |
Cells can be programmed into living devices: Here’s how
Medical Design & Outsourcing The synthetic biological circuits have so far been able to sense a handful of signals which gives them an incomplete idea of conditions in host cells. The circuits also also built using several moving parts like different molecules of DNAs, RNAs and … |
HealthNewsReview.org |
FDA announces action against two stem cell clinics: Is that a ‘crackdown’?
HealthNewsReview.org Numerous news outlets covered the FDA’s announcements yesterday (see here and here) of enforcement action against two stem cell clinics that were alleged to offer unapproved and unsafe treatments. Many reports framed the announcement as a … FDA Targets Unproven, Risky Treatment in Stem Cell Clinics …Newsmax FDA cracks down on stem cell clinics | WPMT FOX43FOX43.com FDA warns US Stem Cell Clinic in Sunrise, Florida, of significant deviationsFlorida Trend Deccan Chronicle –Pain News Network all 24 news articles » |
|
TCR2 Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer …
Markets Insider The oral presentations will discuss rationales and mechanisms for its MHC-independent TRuC™-T cells and provide additional preclinical data for TC-210, the company’s lead program targeting mesothelin-positive solid tumors including ovarian, pancreatic … |